SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is trending after delivering a strong Q4 earnings beat, achieving its first full year of GAAP profitability, and announcing a significant share buyback, prompting community discussions around a potential short squeeze and its "Agentic AI" opportunities, despite a perplexing after-hours price dip.

Incannex Healthcare, Inc. is a biotech company, which engages in developing cannabinoid and psychedelic compound medicines. It focuses on the research and development for medicinal cannabis pharmaceutical products and psychedelic medicine therapies for treatment of a range of indications. The company was founded on April 27, 2001 and is headquartered in Norwest, Australia.

Incannex Healthcare Inc

Incannex Healthcare Limited - ADR

Incannex Healthcare is gaining significant attention as it nears Nasdaq compliance and anticipates imminent End-of-Phase 2 (EOP2) results for its fast-tracked obstructive sleep apnea drug, IHL-42X. The community is actively discussing the stock's strong momentum and potential for a short squeeze due to its reduced float, amidst varying opinions on its valuation and concerns regarding future share dilution.

Memecoin on Cronos launched by the Cro Crow community

crow with knife

Crow With Knife ($CAW) is trending amidst its 2nd anniversary celebration, with its community eagerly discussing ongoing developments like multichain bridging and a deflationary burn mechanism, anticipating significant future growth for the meme coin.

Firefly Aerospace, Inc. engages in the design and manufacture of space launch vehicles. It offers Alpha, Beta, Gamma, and orbital transfer vehicles. The company was founded by Thomas E. Markusic, Mark Watt, and Max Polyakov in January 27, 2017 and is headquartered in Cedar Park, TX.

Firefly Aerospace Inc.

Firefly Aerospace is trending after its Alpha Flight 7 successfully launched a Lockheed Martin payload, sparking renewed community optimism. Following previous delays, investors are actively discussing the implications for the company's standing within the expanding space and defense sectors.

Netskope, Inc. engages in the provision of cloud based security solutions. It offers business developing analytics for visibility, policy enforcement and other cloud solutions. Its products include Netskope one SASE, Netskope one SSE, cloud access security broker, next generation secure web gateway, private access, cloud firewall, SD-WAN and skopeAI. The company was founded by Sanjay Beri, Lebin Cheng, Ravishankar Ithal, and Krishna Narayanaswamy in October 2012 and is headquartered in Santa Clara, CA.

Netskope Inc. - Ordinary Shares - Class A

Netskope is trending after reporting strong revenue and ARR growth, coupled with achieving positive free cash flow for the first time, yet the stock is experiencing a sharp sell-off. The community is actively debating if the market's negative reaction is an overreaction to anticipated share dilution from an upcoming lock-up expiration or if recent guidance is truly lackluster, despite the company's strong positioning in the SASE and AI security market.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is spiking amid escalating geopolitical tensions and attacks on oil facilities near the Strait of Hormuz, raising significant supply disruption concerns. The community is actively debating if recent strategic oil reserve releases are a sufficient buffer or merely a temporary fix against a potentially prolonged high-price environment.

Caesars Entertainment, Inc. engages in the management of casinos and resorts under the Caesars, Harrah's, Horseshoe, and Eldorado brands. It operates through the following segments: Las Vegas, Regional, Caesars Digital, Managed and Branded, and Corporate and Other. The company was founded in 1937 and is headquartered in Reno, NV.

Caesars Entertainment Inc

Caesars Entertainment is trending due to exclusive buyout talks with billionaire Tilman Fertitta for around $34 per share, topping a rival bid from Carl Icahn, sparking intense community discussion among shareholders who feel the offer significantly undervalues the company.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit is experiencing significant price volatility, with many investors accumulating shares around the $130-$140 range, viewing it as an undervalued growth stock with strong fundamentals and a valuable AI data platform for LLMs. Despite a reiterated "Buy" rating from Jefferies, the community expresses frustration over perceived market manipulation, ongoing insider selling, and its recent exclusion from the S&P 500, leading to a prolonged trading range and sharp drops even on green market days.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble is gaining attention as investors discuss Tether's significant financial commitments, including a $250 million spend on ad and cloud services and a substantial equity stake, alongside the transformative Northern Data acquisition, leading to widespread belief that the stock is undervalued and primed for a short squeeze given record short interest.

SSgA Active Trust - State Street Technology Select Sector SPDR ETF

Technology Select Sector SPDR Fund

XLK is trending due to strong earnings and AI infrastructure deals from key constituents like Oracle and Nvidia, fueling discussions about robust demand for AI-related technologies. While some express concern about a broader software sector sell-off and potential market rotation, the community is actively debating if established tech platforms are poised for a rebound amid persistent AI-driven growth.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Denali Gains 11.8% in a Month: Buy, Sell or Hold the Stock? 

DNLI stock jumps as investors eye an April 5, 2026, FDA decision on tividenofusp alfa for Hunter syndrome, a key catalyst for growth.

Here's Why Biogen Inc. (BIIB) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Van ECK Associates Corp Has $149.46 Million Stock Position in Biogen Inc. $BIIB

Van ECK Associates Corp trimmed its holdings in Biogen Inc. (NASDAQ:BIIB - Free Report) by 0.7% during the third quarter, according to its most recent disclosure with the Securities and Exchange...

Jefferies Financial Group Inc. Cuts Stock Holdings in Biogen Inc. $BIIB

Jefferies Financial Group Inc. lowered its position in Biogen Inc. (NASDAQ:BIIB - Free Report) by 17.6% in the third quarter, according to the company in its most recent Form 13F filing with the...

Vinva Investment Management Ltd Lowers Holdings in Biogen Inc. $BIIB

Vinva Investment Management Ltd decreased its holdings in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 34.2% in the 3rd quarter, according to the company in its most recent Form 13F filing...

Victory Capital Management Inc. Purchases 89,530 Shares of Biogen Inc. $BIIB

Victory Capital Management Inc. grew its holdings in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 72.5% during the third quarter, according to the company in its most recent disclosure with...

Biogen CEO touts new era of growth at TD Cowen as 10 Phase 3 programs near key readouts

Biogen (NASDAQ:BIIB) CEO Christopher Viehbacher told investors at TD Cowen's 46th Annual Healthcare Conference that the company is focused on building what he described as a whole new era of growth...

LRMR Stock on the Move: What Sparked the 55% Jump in the Past Month?

Larimar's stock jumps 55% in a month after the FDA grants breakthrough therapy status to its FA drug nomlabofusp and backs a potential accelerated path.

Will AbbVie's Neuroscience Segment Continue to Aid Top Line in 2026?

ABBV's neuroscience unit delivered $10.8B in 2025 and can hit $12.5B in 2026 as Vyalev gains traction and new Parkinson's drug tavapadon awaits FDA review.

The New England Journal of Medicine Publishes First Data to Demonstrate the Potential for Disease Modification in Dravet Syndrome

Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to restoring protein expression by harnessing the bodys potential with RNA medicine, and Biogen Inc. (NASDAQ: BIIB), today...

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.

BIIB
Biogen Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest BIIB News

BIIBBiogen Inc